Sort   by:  
 Page size 
UnknownDNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial.
Not available
S-EPMC5572474 | biostudies-literature
UnknownNeoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Not available
S-EPMC10956403 | biostudies-literature
UnknownSafety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
Not available
S-EPMC9715670 | biostudies-literature
UnknownNeoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
Not available
S-EPMC8571284 | biostudies-literature
UnknownGanitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
Not available
S-EPMC8492731 | biostudies-literature
UnknownCardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study.
Not available
S-EPMC11406334 | biostudies-literature
Unknown2D Speckle Tracking Strain Echocardiography in Multisystem Inflammatory Syndrome in Children: A Multicenter Analysis From the MUSIC Study.
Not available
S-EPMC12661924 | biostudies-literature
UnknownDevelopment of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
Not available
S-EPMC10214179 | biostudies-literature
UnknownResearching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design.
Not available
S-EPMC10197716 | biostudies-literature
UnknownSix-Month Outcomes in the Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children Study.
Not available
S-EPMC11877180 | biostudies-literature
Sort   by:  
 Page size